Chemoinformaics analysis of ETHYL 3-HYDROXYBUTANOATE
| Molecular Weight | 132.159 | nRot | 3 |
| Heavy Atom Molecular Weight | 120.063 | nRig | 0 |
| Exact Molecular Weight | 132.079 | nRing | 0 |
| Solubility: LogS | -7.156 | nHRing | 0 |
| Solubility: LogP | 8.309 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 20.4275 |
| nHD | 1 | BPOL | 14.6425 |
| QED | 0.335 |
| Synth | 2.825 |
| Natural Product Likeliness | 0.655 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.021 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.517 |
| MDCK | 0.00000765 |
| BBB | 0.318 |
| PPB | 0.983005 |
| VDSS | 2.989 |
| FU | 0.0218499 |
| CYP1A2-inh | 0.267 |
| CYP1A2-sub | 0.188 |
| CYP2c19-inh | 0.342 |
| CYP2c19-sub | 0.488 |
| CYP2c9-inh | 0.283 |
| CYP2c9-sub | 0.945 |
| CYP2d6-inh | 0.064 |
| CYP2d6-sub | 0.029 |
| CYP3a4-inh | 0.176 |
| CYP3a4-sub | 0.102 |
| CL | 6.269 |
| T12 | 0.038 |
| hERG | 0.06 |
| Ames | 0.004 |
| ROA | 0.016 |
| SkinSen | 0.94 |
| Carcinogencity | 0.035 |
| EI | 0.942 |
| Respiratory | 0.209 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.967479 |